Variant report
Variant | nsv613423 |
---|---|
Chromosome Location | chr9:11374073-11408865 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs16927457 | chr9:11374073-11374074 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs146081884 | chr9:11374095-11374096 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs547226461 | chr9:11374104-11374105 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs369534819 | chr9:11374109-11374110 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs10756241 | chr9:11374122-11374123 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs377682073 | chr9:11374126-11374127 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs114450353 | chr9:11374150-11374151 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs559019563 | chr9:11374172-11374173 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs575882257 | chr9:11374233-11374234 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs187873360 | chr9:11374263-11374264 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs534841208 | chr9:11374282-11374283 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs574601198 | chr9:11374283-11374284 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs376092085 | chr9:11374304-11374305 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs552769213 | chr9:11374312-11374313 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs572983578 | chr9:11374359-11374360 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs142818135 | chr9:11374362-11374363 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs191164606 | chr9:11374371-11374372 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs182579904 | chr9:11374372-11374373 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs558006317 | chr9:11374486-11374487 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs577878162 | chr9:11374489-11374490 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs563113497 | chr9:11374499-11374500 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs5896449 | chr9:11374508-11374509 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs566350034 | chr9:11374509-11374510 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs80154132 | chr9:11374511-11374512 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs398010310 | chr9:11374525-11374526 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs191578609 | chr9:11374553-11374554 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs531948567 | chr9:11374558-11374559 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs566543820 | chr9:11374567-11374568 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs551956224 | chr9:11374582-11374583 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs565460601 | chr9:11374597-11374598 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs569454039 | chr9:11374610-11374611 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs538107730 | chr9:11374616-11374617 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs554558133 | chr9:11374679-11374680 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs568083976 | chr9:11374703-11374704 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs141536590 | chr9:11374791-11374792 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs528938258 | chr9:11374795-11374796 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs147404377 | chr9:11374805-11374806 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs138848830 | chr9:11374837-11374838 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs577259008 | chr9:11374863-11374864 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs547054657 | chr9:11374880-11374881 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs149366505 | chr9:11374895-11374896 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs148869620 | chr9:11374911-11374912 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs575460779 | chr9:11374912-11374913 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs77033511 | chr9:11374926-11374927 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs532216638 | chr9:11374929-11374930 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs185464079 | chr9:11374938-11374939 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs16927459 | chr9:11374956-11374957 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs529747489 | chr9:11374979-11374980 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs78709159 | chr9:11374988-11374989 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs2152269 | chr9:11375023-11375024 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Disorders of sex development | 21048976 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
abnormal development | 18461090 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma | 19074898 | CNVD |
Malignant melanoma | 19074898 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Cancer | 20164920 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 21764851 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioma | 17123091 | CNVD |
Lung cancer | 16773561 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Gastric cancer | 16891809 | CNVD |
Mental retardation | 17847001 | CNVD |
Cutaneous squamous cell carcinomas | 17420988 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21611746 | CNVD |
Melanoma | 22183965 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:11372800-11377200 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
2 | chr9:11374800-11375400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
3 | chr9:11374800-11375600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
4 | chr9:11374800-11375600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
5 | chr9:11375000-11375400 | Enhancers | H9 Cell Line | embryonic stem cell |
6 | chr9:11375000-11375400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
7 | chr9:11375000-11375600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
8 | chr9:11377200-11377600 | Active TSS | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
9 | chr9:11390400-11390800 | Enhancers | Pancreatic Islets | Pancreatic Islet |
10 | chr9:11401200-11401600 | Active TSS | Fetal Brain Male | brain |
11 | chr9:11402400-11402800 | Active TSS | Fetal Heart | heart |